UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
--------------
Date of Report (Date of earliest event reported): October 23, 2003
EPIX MEDICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 000-21863 04-3030815
------------------------- ----------------------- ----------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
71 ROGERS STREET
CAMBRIDGE, MASSACHUSETTS 02142
-------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 250-6000
-------------------------------------------------------------------------------
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) The following exhibits are furnished with this report:
EXHIBIT NUMBER DESCRIPTION
99.1 Press Release dated October 23, 2003.
ITEM 9. REGULATION FD DISCLOSURE.
The following information is furnished pursuant to Item 12, "Disclosure of
Results of Operations and Financial Conditions."
On October 23, 2003, the Registrant issued a press release to report its
financial results for the quarter ended September 30, 2003. A copy of the press
release is attached to this current report on Form 8-K as Exhibit 99.1.
In accordance with the procedural guidance in SEC Release No. 33-8216, the
information in this Form 8-K and the Exhibit attached to this Form 8-K are being
furnished under "Item 9. Regulation FD Disclosure" rather than under "Item 12.
Disclosure of Results of Operations and Financial Condition." The information
shall not be deemed "filed" for purposes of Section 18 of the Securities
Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the
liabilities of that section, nor shall it be deemed incorporated by reference in
any filing under the Securities Act of 1933 or the Exchange Act, except as
expressly set forth by specific reference in such a filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
EPIX Medical, Inc.
(Registrant)
Date: October 23, 2003 /s/ PEYTON J. MARSHALL
---------------------------------
Peyton J. Marshall
SENIOR VICE-PRESIDENT,
FINANCE AND ADMINISTRATION,
CHIEF FINANCIAL OFFICER
3